Literature DB >> 16959328

The role of the proteasome-ubiquitin pathway in regulation of the IFN-gamma mediated anti-VSV response in neurons.

Jingjun Yang1, Derin Tugal, Carol Shoshkes Reiss.   

Abstract

Pharmacologic inhibition of the proteasome resulted in increased NOS-1 protein levels and increased NO production by neuronal cells. This correlated with an increased antiviral effect of IFN-gamma against the replication of vesicular stomatitis virus (VSV) replication in vitro. We also observed that a regulatory protein, Protein Inhibitor of NOS-1 (PIN) was down-regulated by IFN-gamma treatment, and more ubiquitinated PIN accumulated in IFN-gamma treated neurons. In cells of the reticuloendothelial system, IFN-gamma treatment induces the expression of a set of low molecular weight MHC-encoded proteins (LMPs), which replace the beta-subunit of the proteasome complex during the proteasome neosynthesis, resulting in a complex termed the immunoproteasome. LMP2, -7, and -10 were induced and the immunoproteasome was generated by IFN-gamma treatment in neuronal cells. Importantly, we observed that IFN-gamma induced inhibition of VSV protein synthesis was not dependent on ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959328      PMCID: PMC1764816          DOI: 10.1016/j.jneuroim.2006.07.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  53 in total

1.  Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

Authors:  Reshma Shringarpure; Tilman Grune; Jana Mehlhase; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

2.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

3.  The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome.

Authors:  Jun Imai; Mikako Maruya; Hideki Yashiroda; Ichiro Yahara; Keiji Tanaka
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

4.  Junin virus-induced astrocytosis is impaired by iNOS inhibition.

Authors:  Ricardo M Gómez; Alejandra Yep; Mirta Schattner; María I Berría
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

5.  Protein ISGylation modulates the JAK-STAT signaling pathway.

Authors:  Oxana A Malakhova; Ming Yan; Michael P Malakhov; Youzhong Yuan; Kenneth J Ritchie; Keun Il Kim; Luke F Peterson; Ke Shuai; Dong-Er Zhang
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

6.  PKR is not required for interferon-gamma inhibition of VSV replication in neurons.

Authors:  David A Chesler; Jorge Luis Muñoz-Jordán; Nicola Donelan; Adolfo García-Sastre; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

Review 7.  Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.

Authors:  Peter Michael Kloetzel; Ferry Ossendorp
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

8.  The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells.

Authors:  Rebecca Khor; Lisa J McElroy; Gary R Whittaker
Journal:  Traffic       Date:  2003-12       Impact factor: 6.215

9.  Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro.

Authors:  Sabine Golde; Alasdair Coles; Jonathan A Lindquist; Alastair Compston
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

10.  Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein.

Authors:  Jung-Hwan Kim; Seongman Kang; Joon Kim; Byung-Yoon Ahn
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  7 in total

1.  DISTINCT MECHANISMS OF INHIBITION OF VSV REPLICATION IN NEURONS MEDIATED BY TYPE I AND TYPE II IFN.

Authors:  Paul M D'Agostino; Jingjun Yang; Carol Shoshkes Reiss
Journal:  Virus Rev Res       Date:  2009-01-01

2.  Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma.

Authors:  Michael A Podolsky; Andreas C Solomos; Lisa C Durso; Stephanie M Evans; Glenn F Rall; R Wesley Rose
Journal:  J Neuroimmunol       Date:  2012-07-04       Impact factor: 3.478

3.  Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids.

Authors:  R Antonio Herrera; Joseph H Oved; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

4.  Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma.

Authors:  R Wesley Rose; Anna G Vorobyeva; Jason D Skipworth; Emmanuelle Nicolas; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2007-11-19       Impact factor: 3.478

5.  PIN: a novel protein involved in IFN-gamma accumulation of NOS-1 in neurons.

Authors:  Jingjun Yang; Natalie Nicole Dennison; Carol Shoshkes Reiss
Journal:  DNA Cell Biol       Date:  2008-01       Impact factor: 3.311

6.  Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension.

Authors:  Neeru M Sharma; Andrea S Haibara; Kenichi Katsurada; Xuefei Liu; Kaushik P Patel
Journal:  Nitric Oxide       Date:  2019-10-22       Impact factor: 4.427

7.  Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay.

Authors:  Wim Trypsteen; Pejman Mohammadi; Clarissa Van Hecke; Pieter Mestdagh; Steve Lefever; Yvan Saeys; Pieter De Bleser; Jo Vandesompele; Angela Ciuffi; Linos Vandekerckhove; Ward De Spiegelaere
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.